Loading compound...
Small molecule inhibitor
Gandotinib is a small molecule drug currently being studied in clinical trials (Phase 2) for the treatment of neoplasms (tumors/cancer).
How it worksGandotinib is a small molecule that interacts with various biological targets to inhibit certain cellular activities related to tumor growth.
Used for
Neoplasms (tumors/cancer)
Conditions
Neoplasms
Class
Small moleculeSmall molecule inhibitor
Talk to your doctor
Questions to ask
- ·What phase of clinical trials is Gandotinib currently in?
- ·How does Gandotinib target neoplasms?
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.